中文

金石亚药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.33B+13.7%
Gross profit¥0.21B
Operating income¥0.13B
Net income¥0.12B+86.3%
Gross margin64.7%Net margin 34.9%
Revenue Q/Q+0.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.12B35.3%
R&D¥0.01B2.8%
SG&A¥0.07B22.3%
Tax & other¥0.02B4.7%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

中泰股份广生堂清水源鹏辉能源美康生物运达科技鲍斯股份金雷股份双杰电气康斯特航天智造全信股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies